{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:35:36Z","timestamp":1780472136787,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Misoprostol is the choice drug for inducing an abortion with intrauterine fetal death, but it has several side effects that increase with accumulating the dose received. Induction abortion with cheap and non-invasive methods with minimal complications is essential. This study aimed to compare the effect vaginal misoprostol plus vaginal evening primrose oil capsule with vaginal misoprostol alone on the consequences of abortion in pregnant women with intrauterine fetal death at 12\u201320 weeks of pregnancy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study is a randomized, triple-blind clinical trial with two parallel groups at a ratio of 1:1. We randomized 82 women with indications of termination of pregnancy due to intrauterine fetal death into two groups. The experimental group (n\u2009=\u200942) received 200 mcg of misoprostol tablet with 1000\u00a0mg evening primrose oil capsule intravaginal. The control group (n\u2009=\u200940) received 200 mcg of misoprostol tablet with 1000\u00a0mg evening primrose oil placebo capsule intravaginal. Both groups received the drugs every 4\u00a0h for up to five doses. The primary outcome was the mean induction-to-fetal expulsion interval. Secondary outcomes were the mean dose of misoprostol, the highest pain intensity in the induction-to-fetal expulsion interval, the frequency of participants requiring blood transfusion, curettage, and the frequency of side effects of misoprostol or evening primrose oil. Pain intensity was measured through the Visual Analog Scale.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean age of the experimental group was 32.30\u2009\u00b1\u20096.19 years, and the control group was 30.27\u2009\u00b1\u20097.68 years. The mean gestational age of the experimental group was 15.29\u2009\u00b1\u20092.26 weeks, and the control group was 15.10\u2009\u00b1\u20091.89 weeks. The mean induction-to-fetal expulsion interval in the experimental group (3.12\u2009\u00b1\u20092.17\u00a0h) was significantly lower than that in the control group (8.40\u2009\u00b1\u20094.1\u00a0h) (p\u2009&lt;\u20090.001). The mean dose of misoprostol received in the experimental group (271.42\u2009\u00b1\u2009115.39 mcg) was significantly lower than that in the control group (520\u2009\u00b1\u2009201.53 mcg) (p\u2009&lt;\u20090.001). Also, the mean pain intensity in the experimental group (5.02\u2009\u00b1\u20090.60) was significantly lower than that in the control group (8.65\u2009\u00b1\u20091.001) (p\u2009&lt;\u20090.001). The two groups were not significantly different in the frequency of blood transfusion requirements, analgesia and drug side effects. The need for curettage in the experimental group (4.8%) was significantly lower than that in the control group (47.5%) (p\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Vaginal administration of evening primrose oil with misoprostol reduced duration of time of fetal expulsion, pain intensity, mean dose of misoprostol received, and the need for curettage in participants. Therefore, we suggest this method for induced abortion in women with intrauterine fetal death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>IRCT20181207041873N3. Dated 16\/2\/2021 prospectively registered <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/en.irct.ir\/user\/trial\/53681\/view\">https:\/\/en.irct.ir\/user\/trial\/53681\/view<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-023-04082-w","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T08:47:08Z","timestamp":1689756428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of the effect of vaginal misoprostol and evening primrose oil capsule with misoprostol alone on the consequences of abortion in women with intrauterine fetal death: a randomized clinical trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Hadis","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Batool","family":"Hasanpoor-Azghady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Amiri-Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"4082_CR1","first-page":"41","volume":"1","author":"S Barat","year":"2017","unstructured":"Barat S, Javadian M, Ghanbarpour A. The frequency of causes and risk factors for intrauterine fetal death in Shahid Yahyanezhad Hospital in Babol. Curr Res Med Sci. 2017;1:41\u20135.","journal-title":"Curr Res Med Sci"},{"key":"4082_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1515\/jpm-2017-0073","volume":"45","author":"K Lannaman","year":"2017","unstructured":"Lannaman K, Romero R, Chaiworapongsa T, Kim YM, Korzeniewski SJ, Maymon E, Gomez-Lopez N, Panaitescu B, Hassan SS, Yeo L, Yoon BH. Fetal death: an extreme manifestation of maternal anti-fetal rejection. J Perinat Med. 2017;45:851\u201368. https:\/\/doi.org\/10.1515\/jpm-2017-0073.","journal-title":"J Perinat Med"},{"key":"4082_CR3","volume-title":"Williams Obstetrics","author":"FG Cunningham","year":"2018","unstructured":"Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, Spong CY. Williams Obstetrics. 25th ed. New York: Publisher. McGraw Hill; 2018.","edition":"25"},{"key":"4082_CR4","unstructured":"World Health Organization. Medical management of abortion. 1th ed. World Health Organization; 2019."},{"key":"4082_CR5","doi-asserted-by":"publisher","unstructured":"Morris JL, Winikoff B, Dabash R, Weeks A, Faundes A, Gemzell-Danielsson K, Kapp N, Castleman L, Kim C, Ho PC, Visser GH. FIGO\u2019s updated recommendations for misoprostol used alone in gynecology and obstetrics. 2017. https:\/\/doi.org\/10.1002\/ijgo.12181.","DOI":"10.1002\/ijgo.12181"},{"key":"4082_CR6","doi-asserted-by":"publisher","unstructured":"Reynolds-Wright JJ, Woldetsadik MA, Morroni C, Cameron S. Pain management for medical abortion before 14 weeks\u2019 gestation. Cochrane Database Syst Rev. 2022;5CD013525. https:\/\/doi.org\/10.1002\/14651858.CD013525.pub2.","DOI":"10.1002\/14651858.CD013525.pub2"},{"issue":"6","key":"4082_CR7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1053\/j.semperi.2015.07.006","volume":"39","author":"D Durie","year":"2015","unstructured":"Durie D, Lawal A, Zegelbone P. Other mechanical methods for pre-induction cervical ripening. Semin Perinatol. 2015;39(6):444\u20139. https:\/\/doi.org\/10.1053\/j.semperi.2015.07.006. WB Saunders.","journal-title":"Semin Perinatol"},{"key":"4082_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.30699\/jogcr.6.2.87","volume":"6","author":"B Nouri","year":"2021","unstructured":"Nouri B, Baghestani AR, Pooransari P. Evening Primrose versus Misoprostol for Cervical Dilatation before Gynecologic Surgeries; a double\u2013blind Randomized Clinical Trial. J Obstet Gynecol Cancer Res. 2021;6:87\u201394.","journal-title":"J Obstet Gynecol Cancer Res"},{"key":"4082_CR9","doi-asserted-by":"publisher","first-page":"4e29876","DOI":"10.5812\/thrita.29876","volume":"1","author":"M Vahdat","year":"2015","unstructured":"Vahdat M, Tahermanesh K, Kashi AM, Ashouri M, Dodaran MS, Kashanian M, Alizadeh P, Abed SM, Yazdi AF, Hashemi N, Esfahani SA. Evening primrose oil effect on the ease of cervical ripening and dilatation before operative hysteroscopy. Thrita. 2015;1:4e29876. https:\/\/doi.org\/10.5812\/thrita.29876.","journal-title":"Thrita"},{"key":"4082_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jmig.2011.08.518","volume":"18","author":"PA Aquino","year":"2011","unstructured":"Aquino PA, Fernandez HD, Garcia MI, Barrientos MA, Apepe ET, Pichay RL. Determining the ease of cervical dilation in patients given evening primrose oil (Eveprim\u00ae) intravaginally before hysteroscopy in postmenopausal and nulliparous, premenopausal women ages 37\u201377 years old: a pilot study. J Minim Invasive Gynecol. 2011;18:126\u20137. https:\/\/doi.org\/10.1016\/j.jmig.2011.08.518.","journal-title":"J Minim Invasive Gynecol"},{"key":"4082_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/01.HNP.0000318026.45527.07","volume":"2","author":"D Stonemetz","year":"2008","unstructured":"Stonemetz D. A review of the clinical efficacy of evening primrose. Holist Nurs Pract. 2008;2:171\u20134. https:\/\/doi.org\/10.1097\/01.HNP.0000318026.45527.07.","journal-title":"Holist Nurs Pract"},{"key":"4082_CR12","first-page":"30","volume":"21","author":"S Shahali","year":"2018","unstructured":"Shahali S, Khatami F, Abbaspoor Z, Gheraghian B. The effect of vaginal evening primrose capsule on cervical ripening in nulliparous women with post-term pregnancy: a clinical trial. Iran J Obstet Gynecol Infertil. 2018;21:30\u20138.","journal-title":"Iran J Obstet Gynecol Infertil"},{"key":"4082_CR13","first-page":"1","volume":"41","author":"DN Nonette","year":"2017","unstructured":"Nonette DN. The effectiveness of evening primrose oil gel capsule as a cervical ripening agent during labor induction as measured by Bishop score on term singleton pregnant patients. Philipp J Obstet Gynecol. 2017;41:1\u20134.","journal-title":"Philipp J Obstet Gynecol"},{"key":"4082_CR14","doi-asserted-by":"publisher","DOI":"10.1515\/jcim-2020-0314","author":"S Hemmatzadeh","year":"2021","unstructured":"Hemmatzadeh S, Charandabi SM, Veisy A, Mirghafourvand M. Evening primrose oil for cervical ripening in term pregnancies: a systematic review and meta-analysis. J Complement Integr Med. 2021. https:\/\/doi.org\/10.1515\/jcim-2020-0314. Jul 14.","journal-title":"J Complement Integr Med"},{"key":"4082_CR15","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1002\/ptr.7147","volume":"35","author":"M Moradi","year":"2021","unstructured":"Moradi M, Niazi A, Heydarian Miri H, Lopez V. The effect of evening primrose oil on labor induction and cervical ripening: a systematic review and meta-analysis. Phytother Res. 2021;35:5374\u201383. https:\/\/doi.org\/10.1002\/ptr.7147.","journal-title":"Phytother Res"},{"key":"4082_CR16","first-page":"15","volume":"5","author":"M Faghani Aghoozi","year":"2019","unstructured":"Faghani Aghoozi M, Fayazi S, Mohammadi S, Tehranian N, Amerian M. The effects of evening primerose on clinical obstetrics of Iran: a review study. Scientif J Nurs Midwifery Paramed Fac. 2019;5:15\u201328.","journal-title":"Scientif J Nurs Midwifery Paramed Fac"},{"key":"4082_CR17","doi-asserted-by":"publisher","first-page":"102123","DOI":"10.1016\/j.eujim.2022.102123","volume":"51","author":"A Azad","year":"2022","unstructured":"Azad A, Pourtaheri M, Darsareh F, Heidari S, Mehrnoush V. Evening primrose oil for cervical ripening prior to labor induction in post-term pregnancies: a randomized controlled trial. Eur J Integr Med. 2022;51:102123. https:\/\/doi.org\/10.1016\/j.eujim.2022.102123.","journal-title":"Eur J Integr Med"},{"key":"4082_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.30699\/ajnmc.29.3.181","volume":"29","author":"S Bahmani","year":"2021","unstructured":"Bahmani S, Shaoei R. Comparison of the Effect of Misoprostol and Evening Primrose oil capsules with Misoprostol on Delivery Method in Post-Term pregnancy: clinical trial. Avicenna J Nurs Midwifery Care. 2021;29:181\u20139. https:\/\/doi.org\/10.30699\/ajnmc.29.3.181.","journal-title":"Avicenna J Nurs Midwifery Care"},{"key":"4082_CR19","first-page":"63","volume":"20","author":"S Nikomazhab","year":"2018","unstructured":"Nikomazhab S, Latifi SM, Honarmandpoor A, Abedi P. The effect of evening primrose oil on the prevention of postpartum grief in nulliparous women in a double-blind clinical trial. Iran J Obstet Gynecol Infertil. 2018;20:63\u201374.","journal-title":"Iran J Obstet Gynecol Infertil"},{"key":"4082_CR20","unstructured":"Masumi Z, Khalili A, Delforooz F, Faradmal J, Shayan A. Comparison the effect of evening primrose oil and vitamin E on premenstrual syndrome. Complement Med J Fac Nurs Midwifery 20(23)17;7:1931\u201343."},{"key":"4082_CR21","unstructured":"National Center for Complementary and Alternative Medicine. https:\/\/www.nccih.nih.gov\/health\/evening-primrose-oil. Accessed 13 Jan 2021."},{"key":"4082_CR22","doi-asserted-by":"publisher","unstructured":"Abediasl Z, Sheikh M, Pooransari P, Farahani Z, Kalani F. Vaginal misoprostol versus intravenous oxytocin for the management of second-trimester pregnancies with intrauterine fetal death: a randomized clinical trial. J Obstet Gynaecol Res 2016 Mar;42(3):246\u201351. https:\/\/doi.org\/10.1111\/jog.12910.","DOI":"10.1111\/jog.12910"},{"key":"4082_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-021-05622-w","volume":"22","author":"M Vahedi","year":"2021","unstructured":"Vahedi M, Hasanpoor-Azghady SB, Amiri-Farahani L, Khaki I. Comparison of effect of auriculotherapy and mefenamic acid on the severity and systemic symptoms of primary dysmenorrhea: a randomized clinical trial. Trials. 2021;22:1\u20133. https:\/\/en.irct.ir\/user\/trial\/35967\/view.","journal-title":"Trials"},{"key":"4082_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00404-017-4409-6","volume":"296","author":"\u00cbL Amiri Farahani","year":"2017","unstructured":"Amiri Farahani \u00cbL, Hasanpoor-Azghdy SB, Kasraei H, Heidari T. Comparison of the effect of honey and mefenamic acid on the severity of pain in women with primary dysmenorrhea. Arch Gynecol Obstet. 2017;296:277\u201383. https:\/\/doi.org\/10.1007\/s00404-017-4409-6.","journal-title":"Arch Gynecol Obstet"},{"key":"4082_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.25122\/jml-2019-0021","volume":"12","author":"F Shahnam Nia, Safi","year":"2019","unstructured":"Shahnam Nia, Safi F, Shoukrpour M, Kamali A. An investigation into the effect of evening primrose in dilatation of cervix and pain during and after hysterosalpingography. J Med Life. 2019;12:284. https:\/\/doi.org\/10.25122%2Fjml-2019-0021.","journal-title":"J Med Life"},{"key":"4082_CR26","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.22038\/MJMS.2019.14252","volume":"62","author":"A Asadi","year":"2019","unstructured":"Asadi A, Nematshahi M. The comparison effect of evening primrose capsules to reduce pain after apandectomy-double-blind clinical trial. Med J Mashhad Univers Med Sci. 2019;62:1594\u2013604. https:\/\/doi.org\/10.22038\/MJMS.2019.14252.","journal-title":"Med J Mashhad Univers Med Sci"},{"key":"4082_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.29252\/ajcm.26.1.5","volume":"26","author":"Z Nasrabadi","year":"2019","unstructured":"Nasrabadi Z, Rakhshani MH, Ebadi H, Akbarzadeh R. Comparison of the Effect of Gabapentin and Evening Primrose Oil on Peripheral Neuropathy Pain in patients with type 2 diabetes. Avicenna J Clin Med. 2019;26:5\u201311.","journal-title":"Avicenna J Clin Med"},{"key":"4082_CR28","first-page":"8","volume":"19","author":"F Jafarnejad","year":"2016","unstructured":"Jafarnejad F, Adib Moghaddam E, Ahmad Emami S, Saki A, Hami M, Mohammadzadeh Vatanchi A. Comparative effect of flaxseed and evening primrose oil with vitamin E on severity of cyclic mastalgia in women. Iran J Obstet Gynecol Infertil. 2016;19:8\u201316.","journal-title":"Iran J Obstet Gynecol Infertil"},{"key":"4082_CR29","first-page":"59","volume":"15","author":"S Pruthi","year":"2010","unstructured":"Pruthi S, Wahner-Roedler DL, Torkelson CJ, Cha SS, Thicke LS, Hazelton JH, Bauer BA. Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study. Altern Med Rev. 2010;15:59.","journal-title":"Altern Med Rev"},{"key":"4082_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.18502\/npt.v6i4.1942","volume":"6","author":"M Najafi","year":"2019","unstructured":"Najafi M, Loripoor M, Saghafi Z, Kazemi M. The effect of vaginal evening primrose on the Bishop score of term nulliparous women. Nurs Pract Today. 2019;6:202\u201311. https:\/\/doi.org\/10.18502\/npt.v6i4.1942.","journal-title":"Nurs Pract Today"},{"key":"4082_CR31","first-page":"108","volume":"66","author":"S Khazardoost","year":"2008","unstructured":"Khazardoost S, Moezzi-Madani M. Efficacy of misoprostol for the first trimester pregnancy termination. Tehran Univer Med J. 2008;66:108\u201312.","journal-title":"Tehran Univer Med J"},{"key":"4082_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4314\/eamj.v81i4.9151","volume":"81","author":"L Nyende","year":"2004","unstructured":"Nyende L, Towobola OA, Mabina MH. Comparison of vaginal and oral misoprostol, for the induction of labour in women with intra-uterine foetal death. East Afr Med J. 2004;81:179\u201382. https:\/\/doi.org\/10.4314\/eamj.v81i4.9151.","journal-title":"East Afr Med J"},{"issue":"3","key":"4082_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1067\/mob.2002.121085","volume":"186","author":"JE Dickinson","year":"2002","unstructured":"Dickinson JE, Evans SF. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol. 2002;186(3):470\u20134. https:\/\/doi.org\/10.1067\/mob.2002.121085.","journal-title":"Am J Obstet Gynecol"},{"key":"4082_CR34","first-page":"8","volume":"13","author":"S Rabiee","year":"2009","unstructured":"Rabiee S, Farimani M, Javadian S. A comparison between vaginal misoprostol and expectational management in the termination of early pregnancy failure. Feyz. 2009;13:8\u201312.","journal-title":"Feyz"},{"key":"4082_CR35","unstructured":"Nikoei ghazvini M. Comparison of the effect of misoprostol diet and high-dose oxytocin diet with laminaria on termination of second trimester pregnancies. Thesis PHD. Hormozgan University of Medical Sciences. 2016."},{"key":"4082_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1080\/01443615.2017.1386165","volume":"38","author":"M Kalati","year":"2018","unstructured":"Kalati M, Kashanian M, Jahdi F, Naseri M, Haghani H, Sheikhansari N. Evening primrose oil and labour, is it effective? A randomised clinical trial. J Obstet Gynaecol. 2018;38:488\u201392. https:\/\/doi.org\/10.1080\/01443615.2017.1386165.","journal-title":"J Obstet Gynaecol"},{"key":"4082_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6963-11-224","volume":"11","author":"D Grossman","year":"2011","unstructured":"Grossman D, Constant D, Lince N, Alblas M, Blanchard K, Harries J. Surgical and medical second trimester abortion in South Africa: a cross-sectional study. BMC Health Serv Res. 2011;11:1\u20139. https:\/\/doi.org\/10.1186\/1472-6963-11-224.","journal-title":"BMC Health Serv Res"},{"key":"4082_CR38","first-page":"31","volume":"13","author":"R Mirmohammadi-Maibodi","year":"2005","unstructured":"Mirmohammadi-Maibodi R, Karimzadeh-Maibodi MA, Dehghani Firooz-abadi R, Tabatabaei M. The efficacy of vaginal misoprostol in treatment of missed abortions. J Shahid Sadoughi Univer Med Sci. 2005;13:31\u20138.","journal-title":"J Shahid Sadoughi Univer Med Sci"},{"key":"4082_CR39","first-page":"19","volume":"21","author":"M Ghasemi","year":"2018","unstructured":"Ghasemi M, Arbabzadeh T, Baradaran Z, Sarvi F. Comparison of two dosing regimens of intravaginal misoporostol for second-trimester abortion. Iran J Obstet Gynecol Infertil. 2018;21:19\u201324.","journal-title":"Iran J Obstet Gynecol Infertil"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04082-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-04082-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04082-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T08:47:38Z","timestamp":1689756458000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-04082-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4082"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-04082-w","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research project was confirmed by the Ethics Committee of Iran University of Medical Sciences, Tehran, Iran, with the ethics code of IR.IUMS.REC.1399.1106. After obtaining a sampling license from the Iran University of Medical Sciences. The participants were asked to sign a written informed consent. Respondents were completely informed of the study\u2019s purpose and procedures. Besides, they were assured of the confidentiality of information. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}